EUCTR2006-001337-17-DE
Active, not recruiting
Not Applicable
Characterisation of multiple sclerosis pathology by ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques[Charakterisierung der Multiple Sklerose Pathologie durch ultra small particles of iron oxide (USPIO)” im Vergleich zu konventionellen und fortgeschrittenen MRT Techniken] - MS_USPIO_MPIP
Max-Planck-Institute of Psychiatry0 sitesMarch 26, 2007
ConditionsPatients with Multiple Sclerosis (MS, N=90) and patients with a clinically isolated syndrome (ref. to as CIS in literature, i. e. not a clinically definite MS but a syndrome that may occur as first sign of MS early in the course, N=15) are planned to be investigated in the proposed clinical trial.MedDRA version: 8.1Level: LLTClassification code 10028245Term: Multiple sclerosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Patients with Multiple Sclerosis (MS, N=90) and patients with a clinically isolated syndrome (ref. to as CIS in literature, i. e. not a clinically definite MS but a syndrome that may occur as first sign of MS early in the course, N=15) are planned to be investigated in the proposed clinical trial.
- Sponsor
- Max-Planck-Institute of Psychiatry
- Status
- Active, not recruiting
- Last Updated
- 13 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a. clinically definite MS acc. to McDonald's criteria for the MS group (N\=90\)
- •b. clinically isolated syndrome compatible with MS, no definite diagnosis of MS (for CIS patients, N\=15\)
- •b. age over or equal 18 years
- •d. cognitive abilities to give informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •a. Age below 18 years
- •b. Pregnancy
- •c. Withdrawal of consent
- •d. hypersensitivity to dextrane
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Multiple sclerosis lesion characterization on ultra-high-field MRI: Comparative pilot study of 9.4 vs 7 vs 3 teslaMSmultiple sclerosis10012303NL-OMON52035Zuyderland Medisch Centrum10
Completed
Not Applicable
Diagnostic criteria for Multiple Sclerosis: Impact of high field Magnetic Resonance ImagingMSmultiple sclerosis1000381610012303NL-OMON40083Vrije Universiteit Medisch Centrum30
Recruiting
Not Applicable
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple SclerosisMultiple Sclerosis (MS)NCT05633875Assistance Publique - Hôpitaux de Paris80
Not yet recruiting
Not Applicable
Application of Multiparametric Structural and Functional MRI in Unraveling the Substrates of Cognitive Impairment and Disability in Multiple SclerosisMultiple SclerosisNCT06653283Zhuo Wang104
Completed
Not Applicable
Effects of the Cross-Training in Patients With Multiple SclerosisMultiple SclerosisWeaknessFatigueNCT02010398Università degli Studi di Sassari45